As filed with the Securities and Exchange Commission on March 15, 2023
Registration
No. 333-
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE
SECURITIES ACT OF 1933
89bio, Inc.
(Exact name
of registrant as specified in its charter)
|
|
|
Delaware |
|
36-4946844 |
(State or Other Jurisdiction of Incorporation or Organization) |
|
(I.R.S. Employer Identification No.) |
142 Sansome Street, Second Floor
San Francisco, CA 94104
(Address of Principal Executive Offices, Zip Code)
Amended and Restated 89bio, Inc. 2019 Equity Incentive Plan
89bio, Inc. 2019 Employee Stock Purchase Plan
89bio, Inc. 2023 Inducement Plan
(Full title of the plans)
Rohan Palekar
Chief
Executive Officer
89bio, Inc.
142 Sansome Street, Second Floor
San Francisco, CA 94104
(Name and address of agent for service)
(415) 432-9270
(Telephone number, including area code, of agent for service)
Copies to:
Ryan
A. Murr
Branden C. Berns
Gibson, Dunn & Crutcher LLP
555 Mission Street
San
Francisco, CA 94105
(415) 393-8200
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated
filer, a smaller reporting company, or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
Large accelerated filer |
|
☐ |
|
Accelerated filer |
|
☐ |
|
|
|
|
Non-accelerated filer |
|
☒ |
|
Smaller reporting company |
|
☒ |
|
|
|
|
Emerging growth company |
|
☒ |
|
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐